Soria JC - Search Results

1

Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy.

Felip E, Hirsh V, Popat S, Cobo M, Fülöp A, Dayen C, Trigo JM, Gregg R, Waller CF, Soria JC, Goss GD, Gordon J, Wang B, Palmer M, Ehrnrooth E, Gadgeel SM. Felip E, et al. Among authors: soria jc. Clin Lung Cancer. 2018 Jan;19(1):74-83.e11. doi: 10.1016/j.cllc.2017.06.002. Epub 2017 Jun 23. Clin Lung Cancer. 2018. PMID: 28729180 Free article. Clinical Trial.

2

[Second primary cancers after small-cell lung cancer].

Soria JC, Bréchot JM, Lebeau B, Rochemaure J. Soria JC, et al. Bull Cancer. 1997 Aug;84(8):800-6. Bull Cancer. 1997. PMID: 9339185 Review. French.

3

Do all patients with advanced non-small-cell lung cancer benefit from cisplatin-based combination therapy?

Soria JC, Brisgand D, Le Chevalier T. Soria JC, et al. Ann Oncol. 2001 Dec;12(12):1667-70. doi: 10.1023/a:1013574413217. Ann Oncol. 2001. PMID: 11843242 Free article. Clinical Trial.

4

Uncertain benefit from surgery in patients with lung metastases from breast carcinoma.

Planchard D, Soria JC, Michiels S, Grunenwald D, Validire P, Caliandro R, Girard P, Le Chevalier T. Planchard D, et al. Among authors: soria jc. Cancer. 2004 Jan 1;100(1):28-35. doi: 10.1002/cncr.11881. Cancer. 2004. PMID: 14692021 Free article.

5

Adjuvant chemotherapy and radiotherapy in non-small cell lung cancer.

Erman M, Moretti L, Soria JC, Le Chevalier T, Van Houtte P. Erman M, et al. Among authors: soria jc. Semin Radiat Oncol. 2004 Oct;14(4):315-21. doi: 10.1016/j.semradonc.2004.07.005. Semin Radiat Oncol. 2004. PMID: 15558506 Review.

6

Erlotinib for frontline treatment of advanced non-small cell lung cancer: a phase II study.

Giaccone G, Gallegos Ruiz M, Le Chevalier T, Thatcher N, Smit E, Rodriguez JA, Janne P, Oulid-Aissa D, Soria JC. Giaccone G, et al. Among authors: soria jc. Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6049-55. doi: 10.1158/1078-0432.CCR-06-0260. Clin Cancer Res. 2006. PMID: 17062680 Clinical Trial.

7

Response to erlotinib in first-line treatment of non-small-cell lung cancer in a white male smoker with squamous-cell histology.

Achille M, Gallegos-Ruiz M, Giaccone G, Soria JC. Achille M, et al. Among authors: soria jc. Clin Lung Cancer. 2006 Nov;8(3):214-6. doi: 10.3816/CLC.2006.n.050. Clin Lung Cancer. 2006. PMID: 17239298

8

Leptomeningeal and medullary response to second-line erlotinib in lung adenocarcinoma.

Wagner M, Besse B, Balleyguier C, Soria JC. Wagner M, et al. Among authors: soria jc. J Thorac Oncol. 2008 Jun;3(6):677-9. doi: 10.1097/JTO.0b013e3181757a8b. J Thorac Oncol. 2008. PMID: 18520813 Free article. No abstract available.

9

IFCT-0401 Trial: a phase II study of gefitinib administered as first-line treatment in advanced adenocarcinoma with bronchioloalveolar carcinoma subtype.

Cadranel J, Quoix E, Baudrin L, Mourlanette P, Moro-Sibilot D, Morere JF, Souquet PJ, Soria JC, Morin F, Milleron B; IFCT-0401 Trial Group. Cadranel J, et al. Among authors: soria jc. J Thorac Oncol. 2009 Sep;4(9):1126-35. doi: 10.1097/JTO.0b013e3181abeb5d. J Thorac Oncol. 2009. PMID: 19574932 Free article. Clinical Trial.

10

Use of adjuvant chemotherapy in non-small cell lung cancer in routine practice.

Massard C, Tran Ba Loc P, Haddad V, Pignon JP, Girard P, Monnet I, Trédaniel J, Besse B, Soria JC. Massard C, et al. Among authors: soria jc. J Thorac Oncol. 2009 Dec;4(12):1504-10. doi: 10.1097/JTO.0b013e3181bbf1c9. J Thorac Oncol. 2009. PMID: 19745763 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

736 results

Search Page

Filters